These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 37116665)

  • 21. STIP1 knockdown suppresses colorectal cancer cell proliferation, migration and invasion by inhibiting STAT3 pathway.
    Xia Y; Chen J; Liu G; Huang W; Wei X; Wei Z; He Y
    Chem Biol Interact; 2021 May; 341():109446. PubMed ID: 33766539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. RAC1-GTP promotes epithelial-mesenchymal transition and invasion of colorectal cancer by activation of STAT3.
    Zhou K; Rao J; Zhou ZH; Yao XH; Wu F; Yang J; Yang L; Zhang X; Cui YH; Bian XW; Shi Y; Ping YF
    Lab Invest; 2018 Aug; 98(8):989-998. PubMed ID: 29884911
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TAB3 upregulates PIM1 expression by directly activating the TAK1-STAT3 complex to promote colorectal cancer growth.
    Li Q; Chen L; Luo C; ChenYan ; Ge J; Zhu Z; Wang K; Yu X; Lei J; Liu T; Peng X; Liu X; Yuan R
    Exp Cell Res; 2020 Jun; 391(1):111975. PubMed ID: 32229191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ursolic acid inhibits growth and metastasis of human colorectal cancer in an orthotopic nude mouse model by targeting multiple cell signaling pathways: chemosensitization with capecitabine.
    Prasad S; Yadav VR; Sung B; Reuter S; Kannappan R; Deorukhkar A; Diagaradjane P; Wei C; Baladandayuthapani V; Krishnan S; Guha S; Aggarwal BB
    Clin Cancer Res; 2012 Sep; 18(18):4942-53. PubMed ID: 22832932
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein.
    Zhou H; Bai L; Xu R; Zhao Y; Chen J; McEachern D; Chinnaswamy K; Wen B; Dai L; Kumar P; Yang CY; Liu Z; Wang M; Liu L; Meagher JL; Yi H; Sun D; Stuckey JA; Wang S
    J Med Chem; 2019 Dec; 62(24):11280-11300. PubMed ID: 31747516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BATF3 promotes malignant phenotype of colorectal cancer through the S1PR1/p-STAT3/miR-155-3p/WDR82 axis.
    Li P; Weng Z; Li P; Hu F; Zhang Y; Guo Z; Shen W; Zhao C; Dai S
    Cancer Gene Ther; 2021 May; 28(5):400-412. PubMed ID: 33057139
    [TBL] [Abstract][Full Text] [Related]  

  • 27. LYW-6, a novel cryptotanshinone derived STAT3 targeting inhibitor, suppresses colorectal cancer growth and metastasis.
    Wang H; Liu Z; Guan L; Li J; Chen S; Yu W; Lai M
    Pharmacol Res; 2020 Mar; 153():104661. PubMed ID: 31982491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological Targeting SHP-1-STAT3 Signaling Is a Promising Therapeutic Approach for the Treatment of Colorectal Cancer.
    Fan LC; Teng HW; Shiau CW; Tai WT; Hung MH; Yang SH; Jiang JK; Chen KF
    Neoplasia; 2015 Sep; 17(9):687-696. PubMed ID: 26476076
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of a nitroaromatic nannocystin with potent in vivo anticancer activity against colorectal cancer by targeting AKT1.
    Zhang H; Xie F; Yuan XY; Dai XT; Tian YF; Sun MM; Yu SQ; Cai JY; Sun B; Zhang WC; Shan CL
    Acta Pharmacol Sin; 2024 May; 45(5):1044-1059. PubMed ID: 38326625
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-124-3p suppresses PD-L1 expression and inhibits tumorigenesis of colorectal cancer cells via modulating STAT3 signaling.
    Roshani Asl E; Rasmi Y; Baradaran B
    J Cell Physiol; 2021 Oct; 236(10):7071-7087. PubMed ID: 33821473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. JAK/STAT3 represents a therapeutic target for colorectal cancer patients with stromal-rich tumors.
    Pennel KAF; Hatthakarnkul P; Wood CS; Lian GY; Al-Badran SSF; Quinn JA; Legrini A; Inthagard J; Alexander PG; van Wyk H; Kurniawan A; Hashmi U; Gillespie MA; Mills M; Ammar A; Hay J; Andersen D; Nixon C; Rebus S; Chang DK; Kelly C; Harkin A; Graham J; Church D; Tomlinson I; Saunders M; Iveson T; Lannagan TRM; Jackstadt R; Maka N; Horgan PG; Roxburgh CSD; Sansom OJ; McMillan DC; Steele CW; Jamieson NB; Park JH; Roseweir AK; Edwards J
    J Exp Clin Cancer Res; 2024 Mar; 43(1):64. PubMed ID: 38424636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The HOTAIR/miR-214/ST6GAL1 crosstalk modulates colorectal cancer procession through mediating sialylated c-Met via JAK2/STAT3 cascade.
    Liu B; Liu Q; Pan S; Huang Y; Qi Y; Li S; Xiao Y; Jia L
    J Exp Clin Cancer Res; 2019 Nov; 38(1):455. PubMed ID: 31694696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT3 inhibition sensitizes colorectal cancer to chemoradiotherapy in vitro and in vivo.
    Spitzner M; Roesler B; Bielfeld C; Emons G; Gaedcke J; Wolff HA; Rave-Fränk M; Kramer F; Beissbarth T; Kitz J; Wienands J; Ghadimi BM; Ebner R; Ried T; Grade M
    Int J Cancer; 2014 Feb; 134(4):997-1007. PubMed ID: 23934972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vesicle-associated membrane protein 8 knockdown exerts anti-proliferative, pro-apoptotic, anti-autophagic, and pro-ferroptotic effects on colorectal cancer cells by inhibition of the JAK/STAT3 pathway.
    Xu Y; Yang T; Xu Q; Tang Y; Yang Q
    J Bioenerg Biomembr; 2024 Aug; 56(4):419-431. PubMed ID: 38720136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Th22 cell accumulation is associated with colorectal cancer development.
    Huang YH; Cao YF; Jiang ZY; Zhang S; Gao F
    World J Gastroenterol; 2015 Apr; 21(14):4216-24. PubMed ID: 25892871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Uncovering the action mechanism of homoharringtonine against colorectal cancer by using network pharmacology and experimental evaluation.
    Qu M; Li J; Yuan L
    Bioengineered; 2021 Dec; 12(2):12940-12953. PubMed ID: 34847838
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ursolic acid promotes colorectal cancer cell apoptosis and inhibits cell proliferation via modulation of multiple signaling pathways.
    Lin J; Chen Y; Wei L; Shen A; Sferra TJ; Hong Z; Peng J
    Int J Oncol; 2013 Oct; 43(4):1235-43. PubMed ID: 23900560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of SLC9A8 Promotes Epithelial-Mesenchymal Transition and Metastasis in Colorectal Cancer Cells via the IL6-JAK1/STAT3 Signaling Pathway.
    Liu W; Geng C; Li X; Li Y; Song S; Wang C
    Dig Dis Sci; 2023 May; 68(5):1873-1884. PubMed ID: 36583805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIF-3α1 promotes colorectal tumor cell growth by activation of JAK-STAT3 signaling.
    Xue X; Jungles K; Onder G; Samhoun J; Győrffy B; Hardiman KM
    Oncotarget; 2016 Mar; 7(10):11567-79. PubMed ID: 26871465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.